Laboratory Methods for COVID-19 Diagnosis
International Blood Research & Reviews,
Page 53-59
DOI:
10.9734/ibrr/2021/v13i130160
Abstract
Coronaviruses are a group of related RNA viruses that cause disease in mammals and birds. Covid-19 infection occurs due to an RNA virus which is single-stranded, called SARS-CoV-2; this virus is similar to SARS-CoV. This review throws light on the available laboratory techniques used for testing coronavirus. Certain challenges are encountered during the development of a diagnostic test for a novel pathogen, which depends on sensitivity of the method, that is, the potential in detecting very low pathogen level for early laboratory diagnosis, produce little or no interference with other strains of the virus, and produce results rapidly. Since the time of incubation and clinical manifestation of the infection are relatively the same with SARS, the widespread and effect of COVID-19 globally serve as the basis why the development of quick and reliable laboratory methods are necessary. Samples that could be collected for covid-19 testing includes blood (especially for screening purpose), nasal and throat swab. Currently, the gold standard method for laboratory diagnosis of Covid-19 infection is RT-PCR, which serves as a confirmatory method for Covid-19 testing. EIA and SVN laboratory techniques are other techniques used in detecting the viral infection. In addition, Rapid Diagnostic Testing (RDT) are currently developed for point-of-care testing, and often used as a screening method of Covid-19 infections. Early detection of the virus remains the primary focus for the treatment and control of SARS-CoV-2 infections. Therefore, this review was aimed at the available laboratory methods used in the diagnosis for coronavirus infection.
Keywords:
- SARS-CoV-2
- primer
- probe
- gene
- antibody
- antigen
How to Cite
References
Shuo S, Gary W, Weifeng S, Jun L, Alexander CKL, Jiyong Z, et al. Epidemiology, genetic recombination, and Pathogenesis of coronaviruses. Trends Microbiology. 2016;24(6):490–502.
Ksiazek TG, Erdman D, Goldsmith CS. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1953–1966.
Peiris JSM, Lai ST, LLM Poon LLM, Guan Y, Yam LYC, Lim W, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361(9366):1319–1325.
Christian D, Michael S, Victor MC, Wulf H, Gregor S, Stefan S, et al. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013;13(9);745–751.
Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown Etiology in Wuhan China: The Mystery and the Miracle. J Med Virology. 2020;92(4):401–402.
Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11(1):59.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H. Genomic characterization and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565–574.
DOI: 10.1016/S0140-6736(20)30251-8
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-574.
Andersen KG, Rambaut A, Lipkin WI. The proximal origin of SARS-CoV-2. Nature Medicine. 2020;26(4):450- 452.
Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020;24(1):91-98.
CDC. Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19); 2020a.
Available:https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelinesclinical-specimens.html
Accessed on Feb 2020.
Falsey AR, Formica MA, Walsh EE. Simple method for combining sputum and nasal samples for virus detection by reverse transcriptase PCR. J Clin Microbiology. 2012;50(8):2835.
World Health Organization. Coronavirus Disease (COVID-19) Technical Guidance: Laboratory Testing for 2019-nCoV in Humans; 2020b.
Available:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical~guidance/laboratory-guidance
Accessed on Feb. 2020.
Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:2000045.
World Health Organization. Naming the Coronavirus Disease (COVID19) and the Virus that Causes It; 2020a.
Available:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/namingthe-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
Accessed Feb 2020.
Felix EK, Roseline E. Update on covid-19 infection and ivermectin treatment. International Journal of Pathogen Research. 2021;7(1):9-16.
Gauger PC, Vincent AL. Serum virus neutralization assay for detection and quantitation of serum-neutralizing antibodies to influenza A virus in swine. Methods in Molecular Biology. 2014; 1161(1):313-324.
-
Abstract View: 462 times
PDF Download: 197 times
